Trokendi XR Approval History
- FDA approved: Yes (First approved August 16th, 2013)
- Brand name: Trokendi XR
- Generic name: topiramate
- Company: Supernus Pharmaceuticals, Inc.
- Treatment for: Epilepsy
Trokendi XR (topiramate) is an antiepileptic drug indicated for the treatment of epilepsy.
Development History and FDA Approval Process for Trokendi XR
|Aug 19, 2013||Supernus Announces Final FDA Approval and Upcoming Launch of Trokendi XR|
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.